Literature DB >> 12170219

Extent of thrombus evaluated in patients with recurrent and first deep vein thrombosis.

Astrid M Fink1, Wolfgang Mayer, Andreas Steiner.   

Abstract

OBJECTIVES: The objective of this retrospective study was to document the extent of thrombus in patients with recurrent and first deep vein thrombosis (DVT). PATIENTS AND METHODS: A total of 864 patients with DVT of the leg were enrolled in the study. They were divided into two groups: patients with recurrent DVT (n = 233) of the leg, and patients with first DVT of the leg (n = 631). In both groups the extent of the thrombus was evaluated by duplex scanning, contrast venography, or magnetic resonance imaging. Thrombus involving veins distal to the popliteal vein was classified as distal DVT, whereas involvement of the popliteal vein and proximal was classified as proximal DVT.
RESULTS: We could demonstrate that involvement of proximal segments (CEAP anatomic classification 1-9) occurred significantly more often in patients with recurrent DVT than in patients with the first DVT (P <.001). The incidence of pulmonary embolism (PE) and the clinical symptoms of PE were equally distributed between patients with recurrent DVT and those with first DVT (P >.05). Only one patient died as a consequence of PE in our patient sample.
CONCLUSIONS: In our experience, patients with recurrent DVT have a higher frequency of proximal DVT. Nevertheless, the incidence of PE is similar in patients with recurrent and those with first DVT.

Entities:  

Mesh:

Year:  2002        PMID: 12170219     DOI: 10.1067/mva.2002.125481

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  1 in total

1.  Correlation between the site of pulmonary embolism and the extent of deep vein thrombosis: evaluation by computed tomography pulmonary angiography and computed tomography venography.

Authors:  Yosuke Horii; Norihiko Yoshimura; Yoshiro Hori; Satoshi Takaki; Toru Takano; Shoichi Inagawa; Hidefumi Aoyama
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.